Navigation Links
Zargis Medical Strikes Gold at 2010 Edison Awards

STAMFORD, Conn., May 14 /PRNewswire/ -- Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp. (Nasdaq: SPDE), today announced that its Zargis Cardioscan device and the compatible 3M™ Littmann® Electronic Stethoscope Model 3200 were the joint recipients of a Gold Award on April 29th at The Edison Best New Products Award gala, presented by Discovery Channel in New York City. The prestigious Gold Award is the top honor given by the Edison Award Steering Committee for product excellence in innovation, creativity and ingenuity, as demonstrated by inventor Thomas Alva Edison. Zargis and 3M were recognized in the Electronics and Computers category—the category in which the Apple® iPhone was the 2009 Gold Award winner.

Zargis Cardioscan software supports physicians in analyzing cardiac sounds for the identification and classification of suspected murmurs, which can be signs of heart disease, and allows healthcare professionals to record, visualize and transmit recordings made with a stethoscope. The software represents a breakthrough in computer-aided auscultation that has the potential to reduce unnecessary referrals.

"Pairing the Littmann Electronic Stethoscope Model 3200 with Zargis Cardioscan software is a huge advancement in changing the way clinicians listen to and interpret heart sounds," said Debra Rectenwald, president and general manager, 3M Infection Prevention Division.

About Zargis Medical Corp.

Zargis is a global medical device company focused on improving health outcomes and cost-effectiveness through diagnostic support software and innovation. Zargis is majority-owned by Speedus Corp. (Nasdaq: SPDE), and both 3M Company and Siemens Corporate Research, a division of Siemens AG (NYSE: SI), hold equity positions.

For additional information about Zargis or Speedus Corp., contact Peter Hodge at 888.773.3669 (ext. 23) or, or visit the following Web sites: and

Statements contained herein that are not historical facts, including but not limited to statements about the Company's product, corporate identity and focus, may be forward-looking statements that are subject to a variety of risks and uncertainties. There are a number of important factors that could cause actual results to differ materially from those expressed in any forward-looking statements made by the Company, including, but not limited to, the continuing development of the Company's sales, marketing and support efforts.

SOURCE Speedus Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Speedus Engages Morgan Joseph to Evaluate Strategic Alternatives for Zargis Subsidiary
2. Zargis to Release Trial Version of Cardioscan while Exhibiting with 3M(TM) Littmann(R) at American Heart Association Conference
3. Zargis Cardioscan Cleared for Sale in Canada
4. Zargis Cardioscan(TM) Featured on The Early Show on CBS
5. Zargis Cardioscan The Intelligent Stethoscope Now Available on
6. Zargis Cardioscan Jointly Named as Finalist in 2010 Edison Best New Product Awards
7. Zargis StethAssist & Zargis Cardioscan Cleared for Sale in Australia
8. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
9. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
10. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
11. Globus Medical Raises $110 Million in Series E Financing Round
Post Your Comments:
(Date:10/13/2015)... , October 13, 2015 ... World Thrombosis Day Interactive Infographic   --> ... World Thrombosis Day  to promote vital global awareness ... and symptoms. Thrombosis is the formation of potentially ... - resulting in venous thromboembolism (VTE) - or the ...
(Date:10/12/2015)... Given the intricacy of the anatomy and physiology of ... drug effectively to a specific ocular site. Several barriers have ... include dilution of a drug by tears, clearance of a ... issues with respect to the cornea, sclera and choroid. Approximately ... due to the aforementioned barriers. --> Given ...
(Date:10/12/2015)... 12, 2015  The Pharmacy Compounding Accreditation Board ... Pharmacy in Costa Mesa , ... the pharmacy,s commitment to meeting and/or exceeding national ... --> --> ... --> --> Harbor Compounding ...
Breaking Medicine Technology:
(Date:10/13/2015)... ... ... Symposium Chairman, Dr. Rod J. Rohrich is pleased to announce that registration ... 2nd and 3rd, 2016. The annual meeting, along with the Dallas Rhinoplasty ... the world. , Key topics at this year's event will include discussions on efficacy ...
(Date:10/13/2015)... ... October 13, 2015 , ... e-con Systems Inc., a ... announced See3CAM_CU40, the industry’s first RGB-IR pixel format camera with a USB ... member of e-con’s See3CAM family of UVC USB 3.0 cameras, is based on the ...
(Date:10/13/2015)... ... October 13, 2015 , ... Altec ... their Title Sponsorship of Synergy 2015. The annual WennSoft KEY2ACT user conference will ... Ranch and will unite customers, partners, WennSoft team members and sponsors to facilitate ...
(Date:10/13/2015)... ... October 13, 2015 , ... Tempe Dental Care, a leading Tempe dentists’ office, ... IV sedation dentistry for more than 5 years. A leading cause of emergency ... painful if treatment is not timely. , Sedation dentistry provides an ...
(Date:10/13/2015)... ... October 13, 2015 , ... Breathing is ... do not breathe correctly. According to T’ai Chi (also spelled “Taiji”) and Qigong ... breathe correctly, in concert with the 7,000 year old tradition they teach, can ...
Breaking Medicine News(10 mins):